Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Nov 07, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001950047-24-008256.pdf
0001950047-24-008256.rtf
0001950047-24-008256.xls
Nov 07, 2024 SC 13G/A An amendment to the SC 13G filing View HTML
0001193125-24-253265.pdf
0001193125-24-253265.rtf
Nov 06, 2024 8-K Report of unscheduled material events or corporate event View HTML
0001714899-24-000215.pdf
0001714899-24-000215.rtf
0001714899-24-000215.xls
Nov 06, 2024 10-Q Quarterly report which provides a continuing view of a company's financial position View HTML
0001714899-24-000216.pdf
0001714899-24-000216.rtf
0001714899-24-000216.xls
Nov 05, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000208.pdf
0001714899-24-000208.rtf
0001714899-24-000208.xls
Oct 22, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000206.pdf
0001714899-24-000206.rtf
0001714899-24-000206.xls
Oct 21, 2024 SC 13G/A An amendment to the SC 13G filing View HTML
0002012383-24-000963.pdf
0002012383-24-000963.rtf
Oct 18, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001950047-24-007802.pdf
0001950047-24-007802.rtf
Oct 10, 2024 8-K Report of unscheduled material events or corporate event View HTML
0001714899-24-000205.pdf
0001714899-24-000205.rtf
0001714899-24-000205.xls
Oct 02, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000200.pdf
0001714899-24-000200.rtf
0001714899-24-000200.xls
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • …
  • Next page ›
  • Last page »
Displaying 61 - 70 of 710 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use